期刊文献+

子宫腺肌病组织中PRL-3、VEGF的表达变化及意义 被引量:4

Expression changes of phosphatase of regenerating liver-3 and vascular endothelial growth factor in the adenomyosis
下载PDF
导出
摘要 目的观察子宫腺肌病(AM)组织中促肝细胞再生磷酸酶-3(PRL-3)及血管内皮细胞生长因子(VEGF)的表达变化,并探讨其意义。方法选取30例AM患者异位内膜(异位组)、在位内膜组织(在位组),以及30例子宫肌瘤患者正常子宫内膜组织(对照组),采用免疫组化法检测各组织中PRL-3、VEGF的表达水平。结果 VEGF及PRL-3在异位组表达显著高于在位组及对照组(P均<0.01),且在在位组的表达高于对照组(P均<0.05)。异位组、在位组增生期与分泌期内膜中PRL-3的表达均高于同时相对照组(P均<0.05)。对照组中VEGF在分泌期内膜中的表达高于增生期(P<0.05)。PRL-3与VEGF在在位组中的表达呈正相关关系(r=0.439,P<0.05)。结论 PRL-3及VEGF在AM异位内膜中呈高表达,二者可能与AM的发病有关。 Objective To observe the expression changes of phosphatase of regenerating liver-3 (PRL-3) and vascular endothelial growth factor (VEGF) in adenomyosis (AM) tissues and to investigate the clinical significance.Methods The samples collected for this study were 30 cases of ectopic endometrium (ectopic group),30 cases of eutopic endometrium(eutopic group)from patients with AM and 30 cases of control endometrium (control group).The expression of PRL-3 and VEGF were measured by immunohistochemistry.Results The expression of PRL-3 and VEGF in ectopic group was increased as compared with that in eutopic and control groups; and eutopic group was higher than control group (all P <0.05).The expression of PRL-3 in hyperplasia period and secretory period of the ectopic and eutopic groups was higher than that of the control group (all P < 0.05).In the control group,the expression of VEGF in secretory period was higher than in hyperplasia period (P < 0.05).In the eutopic group,the expression of PRL-3 was positively correlated with expression of VEGF (r =0.439,P < 0.05).Conclusion The high expression of PRL-3 and VEGF in ectopic and eutopic endometrium may be associated with the onset of AM.
出处 《山东医药》 CAS 2013年第34期10-12,共3页 Shandong Medical Journal
基金 泸州市科学技术研究项目(200727)
关键词 子宫腺肌病 促肝细胞再生磷酸酶3 血管内皮细胞生长因子 adenomyosis phosphatase of regenerating liver-3 vascular endothelial growth factor
  • 相关文献

参考文献14

  • 1郎景和.子宫内膜异位症研究的任务与展望(之一)[J].中华妇产科杂志,2006,41(5):289-290. 被引量:124
  • 2Stephens B J, Han H, Gokhale V, et al. PRL phosphatases as po- tential molecular targets in cancer[ J ]. Mol Cancer Ther, 2005,4 (11) :1653 - 1661.
  • 3Wu M, Yih H, Hong N. The role of cytokines in endometriosis [J]. Am J Reprod Immunol, 2003,49(5) :285-296.
  • 4Li Z, Zhan W, Wang Z, et al. Inhibition of PRL-3 gene expres- sion in gastric cancer cell line SGC7901 viamicro RNA suppressed reduces peritoneal metastasis [J]. Biochem Biophys Res Com- mun, 2006,34(8) :229-237.
  • 5Miskad UA, Semba S, Kato H, et al. Expression of PRL-3 Phos- Pbatase in human gastric carcinomas: close correlation with inva- sion and metastasis [ J ]. Patllobiology, 2004,71 ( 4 ) : 176 -184.
  • 6Bessette DC, Qiu D, Pallen CJ. PRL PTPs : mediators and markers of cancer progression [J]. Cancer Metastasis Rev, 2008,27 (2) : 231-252.
  • 7李燕,郑芹林,唐利,王明明,龙玉芬,陈枫,史小玲,李宗恒.Intβ1、MMP-2及PRL-3在子宫内膜异位症中的表达[J].山东医药,2012,52(41):35-37. 被引量:2
  • 8张雯,朱慧莉,黄薇.血管内皮生长因子与子宫内膜血管生成的研究进展[J].国外医学(妇产科学分册),2004,31(4):249-252. 被引量:6
  • 9Toi M, Matsumoto T, Bando H. Vascular endothelial growth fac- tor : its prognostic, predictive, and therapeutic implictions [ J ]. Lancet Oncol, 2001,2 ( 11 ) : 67-73.
  • 10Kodama J, Shinyo Y, Hasengaowa T, et al. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer[J]. Oncol Rep, 2005,14 ( 1 ) :89-92.

二级参考文献36

  • 1郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:278
  • 2刘玉琴,高英敏,王秀华.子宫内膜癌组织中FHIT、MMP-2的表达与临床病理的相关性研究[J].实用妇产科杂志,2005,21(4):223-225. 被引量:7
  • 3王巧英,李兆艾.子宫内膜异位症患者血管内皮生长因子的检测及其临床意义[J].山西医药杂志,2006,35(6):500-502. 被引量:3
  • 4Grinnond S, Lagercrantz J, Drinkwater C, et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res,1996, 6:124-131.
  • 5Joukov V, Kumar V, Jeltsch M, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 1997, 16:3898-3911.
  • 6Aehen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for tyrosine kinases VEGF receptor2(Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci U S A,1998, 95:548-553.
  • 7Cao Y, Chen H, Zhou L ,et al. Heterodimers placenta growth factor/vascular endothelial growth factor .J Biol Chem, 1996, 271 (6):3154.
  • 8Yang S, Graham J, Kahn JW, et al. Functional roles for PECAM-1 (CD31)and VE-cadherin(CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol, 1999, 155(3):887-895.
  • 9Abberton KM, Taylor NH, Healy DL, et al. Vascular smooth muscle cell proliferation in arterioles of the human endometrium, Hum Reprod, 1999, 14(4): 1072-1079.
  • 10Gargett CE, Lederman F, Heryanto B, et al. Focal vascular endothelial growth factor correlates with angiogenesis in human endometriurm. Role of intravascular neutrophils. Hum Reprod, 2001, 16(6):1065-1075.

共引文献133

同被引文献32

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部